Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO, July 18, 2024 SAN DIEGO, July 18, 2024 /PRNewswire/ -- As Illumina, Inc...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO, July 11, 2024 SAN DIEGO, July 11...
Illumina acquires Fluent BioSciences to accelerate single-cell analysis and discovery to a broader customer...
Illumina completes the divestiture of GRAIL PR Newswire SAN DIEGO, June 24, 2024 GRAIL spin-off complete; GRAIL to begin regular way trading as...
Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations PR...
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK...
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at...
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares PR Newswire SAN DIEGO, June 3, 2024...
Illumina appoints Everett Cunningham Chief Commercial Officer PR Newswire SAN DIEGO, June 3, 2024 Cunningham...
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.